Tag: Biological therapy for inflammatory bowel disease

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Biological therapy for inflammatory bowel disease

Experimental treatment against Covid-19 developed in Yucatan, promises to overcome vaccine

Added to Collection on: 2021-03-25 15:22:30

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Biotechnology
Immune system
Monoclonal antibody
Antiviral drug
Antibody
Vaccine
Neutralizing antibody
Biological therapy for inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences plc ("Tiziana" or the "Company") - Gabriele Cerrone, ...

Added to Collection on: 2021-03-29 06:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Monoclonal antibodies
Interleukin-6 receptor
Anti-CD3 monoclonal antibody
Foralumab
Psoriasis
Ulcerative colitis
Monoclonal antibody therapy
Biological therapy for inflammatory bowel disease
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
C4X Discovery agrees licensing deal with Sanofi

Added to Collection on: 2021-04-12 08:48:45

Tags for this article:

Medical specialties
Autoimmune diseases
Psoriasis
Medicine
Health sciences
Pharmaceutical industry
Sanofi
Psoriatic arthritis
Medication
Biological therapy for inflammatory bowel disease
C4X Discovery

Click the tags to see associated articles and topics

View Article Details
Sanofi Tries Again With Cytokines, Inking R&D Alliance With Startup Synthekine

Added to Collection on: 2024-01-29 19:42:43

Tags for this article:

Immunology
Interleukins
Cytokines
CAC 40
Sanofi
Cytokine
Interleukin 2
Interleukin 10
Inflammation
Cytokine delivery systems
Biological therapy for inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
AbbVie inks immune disorder drug licensing deal with China's FutureGen - WKZO

Added to Collection on: 2024-06-13 15:09:43

Tags for this article:

Autoimmune diseases
Abdominal pain
Diarrhea
Inflammatory bowel disease
Ulcerative colitis
AbbVie
Adalimumab
Biopharmaceutical
Crohn's disease
Colitis
Ulcer
Biological therapy for inflammatory bowel disease
United States
Landos Biopharma

Click the tags to see associated articles and topics

View Article Details
NEJM: Results From Targeted Therapy for Ulcerative Colitis Study - Newswise

Added to Collection on: 2024-09-26 00:12:40

Tags for this article:

Autoimmune diseases
Abdominal pain
Diarrhea
Inflammatory bowel disease
Gastrointestinal tract disorders
Ulcerative colitis
Crohn's disease
David T. Rubin
Colitis
Management of ulcerative colitis
Autoimmune disease
Biological therapy for inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
Orphagen Pharmaceuticals: Up To $1.7 Million NIH Funding Award Received For ... - Pulse 2.0

Added to Collection on: 2024-12-09 21:33:35

Tags for this article:

Autoimmune diseases
Abdominal pain
Inflammatory bowel disease
Integrins
LPAM-1
Ulcerative colitis
CCR9
Vedolizumab
Crohn's disease
Gastrointestinal tract
Shomron Ben-Horin
Biological therapy for inflammatory bowel disease
Orphagen Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in ...

Added to Collection on: 2025-04-21 13:59:51

Tags for this article:

Immunology
Biotechnology
Interleukins
Monoclonal antibodies
Immune system
Biopharmaceutical
Interleukin 17
Psoriasis
Antibody
Immunotherapy
Biological therapy for inflammatory bowel disease
Tolerx
Akeso Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Biologics, Inc. Announces a Phase 3 Study of Picankibart ( Anti-IL-23p19 Antibody ...

Added to Collection on: 2025-05-29 09:08:14

Tags for this article:

Monoclonal antibodies
Autoimmune diseases
Psoriasis
Biotechnology
Biopharmaceutical
Biological therapy for inflammatory bowel disease
GSK2831781
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Johnson and Johnson Discontinues Development of Nipocalimab in Combination with Anti ...

Added to Collection on: 2025-09-03 17:44:59

Tags for this article:

Monoclonal antibodies
Biotechnology
Rheumatology
Autoimmune diseases
Connective tissue diseases
TNF inhibitor
Rheumatoid arthritis
Arthritis
Sjögren's disease
Biopharmaceutical
Infliximab
Biological therapy for inflammatory bowel disease
Johnson and Johnson

Click the tags to see associated articles and topics

View Article Details
Book a Demo